Medical care costs of patients with rheumatoid arthritis during the prebiologics period in Japan: A large prospective observational cohort study

Modern Rheumatology

Volumn 20, Issue 1, 2010, Pages 46-53

  Tanaka, Eiichi ^a,b,c   Inoue, Eisuke ^c   Mannalithara, Ajitha ^a,b   Bennett, Mihoko ^d   Kamitsuji, Shigeo ^c   Taniguchi, Atsuo ^c   Momohara, Shigeki ^c   Hara, Masako ^c   Singh, Gurkirpal ^a,b   Yamanaka, Hisashi ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Institute of Clinical Outcomes Research and Education   (United States)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Disease Activity Score; Health Assessment Questionnaire; Medical costs; Observational cohort study; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; AGING; ARTICLE; COHORT ANALYSIS; COST BENEFIT ANALYSIS; COST OF ILLNESS; DISABILITY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HEALTH CARE COST; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; OBSERVATIONAL STUDY; OCCUPATIONAL THERAPY; OUTPATIENT CARE; PHYSIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS;

AMBULATORY CARE; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL PRODUCTS; DISABILITY EVALUATION; DRUG COSTS; FEMALE; HEALTH CARE COSTS; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 76649127064     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0236-3     Document Type: Article

References (29)

1. KM Pugner DI Scott JW Holmes K Hieke 2000 The costs of rheumatoid arthritis: an international long-term view Semin Arthritis Rheum 29 5 305 320 10.1016/S0049-0172(00)80017-7 1:STN:280:DC%2BD3c3mtlWjtw%3D%3D 10805355
2. NJ Cooper 2000 Economic burden of rheumatoid arthritis: a systematic review Rheumatology (Oxford) 39 1 28 33 10.1093/rheumatology/39.1.28 1:STN:280:DC%2BD3c7jtFWisg%3D%3D
3. AL Weaver 2004 The impact of new biologicals in the treatment of rheumatoid arthritis Rheumatology (Oxford) 43 Suppl 3 iii17 iii23 10.1093/rheumatology/keh203
4. DE Furst FC Breedveld JR Kalden JS Smolen GR Burmester JW Bijlsma M Dougados P Emery EC Keystone L Klareskog PJ Mease 2005 Updated consensus statement on biological agents, specifically tumor necrosis factor alpha (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005 Ann Rheum Dis 64 Suppl 4 iv2 iv14 10.1136/ard.2005.044941 1:CAS:528:DC%2BD2MXht1amtL7L 16239380 (Pubitemid 41532009)
5. H Yamanaka E Inoue G Singh E Tanaka A Nakajima A Taniguchi M Hara T Tomatsu N Kamatani 2007 Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan Mod Rheumatol 17 4 283 289 10.1007/s10165-007-0587-6 17694260 (Pubitemid 47263818)
6. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper LA Healey SR Kaplan MH Liang HS Luthra, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 10.1002/art.1780310302 1:STN:280:DyaL1c7pt1Ohsg%3D%3D 3358796
7. H Yamanaka S Tohma 2006 Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice Mod Rheumatol 16 2 75 76 10.1007/s10165-006-0464-8 16633925
8. Y Matsuda G Singh H Yamanaka E Tanaka W Urano A Taniguchi T Saito M Hara T Tomatsu N Kamatani 2003 Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis Arthritis Rheum 49 6 784 788 10.1002/art.11465 14673964
9. E Tanaka A Saito S Kamitsuji T Yamada A Nakajima A Taniguchi M Hara T Tomatsu H Yamanaka N Kamatani 2005 Impact of shoulder, elbow, and knee joint involvement on assessment of rheumatoid arthritis using the American College of Rheumatology Core Data Set Arthritis Rheum 53 6 864 871 10.1002/art.21589 16342105 (Pubitemid 41811127)
10. A Nakajima S Kamitsuji A Saito E Tanaka K Nishimura N Horikawa N Ozaki T Tomatsu M Hara N Kamatani H Yamanaka 2006 Disability and patient's appraisal of general health contribute to depressed mood in rheumatoid arthritis in a large clinical study in Japan Mod Rheumatol 16 3 151 157 10.1007/s10165-006-0475-5 16767553 (Pubitemid 43871690)
11. E Tanaka E Inoue Y Kawaguchi T Tomatsu H Yamanaka M Hara N Kamatani 2006 Acceptability and usefulness of mizoribine in the management of rheumatoid arthritis in methotrexate-refractory patients and elderly patients, based on analysis of data from a large-scale observational cohort study Mod Rheumatol 16 4 214 219 10.1007/s10165-006-0487-1 1:CAS:528:DC%2BD28XotVymsb4%3D 16906370 (Pubitemid 44227340)
12. T Yamada A Nakajima E Inoue E Tanaka M Hara T Tomatsu N Kamatani H Yamanaka 2006 Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan Ann Rheum Dis 65 12 1661 1663 10.1136/ard.2005.047274 1:STN:280:DC%2BD28jgvFKjtQ%3D%3D 16837491 (Pubitemid 44799684)
13. T Furuya S Kotake E Inoue Y Nanke T Yago T Kobashigawa N Ichikawa E Tanaka S Momohara A Nakajima M Hara T Tomatsu H Yamanaka N Kamatani 2007 Risk factors associated with incident clinical vertebral and nonvertebral fractures in Japanese women with rheumatoid arthritis: a prospective 54-month observational study J Rheumatol 34 2 303 310 17143973
14. N Iikuni A Nakajima E Inoue E Tanaka H Okamoto M Hara T Tomatsu N Kamatani H Yamanaka 2007 What's in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity Rheumatology (Oxford) 46 5 846 848 10.1093/rheumatology/kel414 1:STN:280:DC%2BD2s3jvVGiug%3D%3D (Pubitemid 47061720)
15. E Tanaka A Mannalithara E Inoue M Hara T Tomatsu N Kamatani g Singh H Yamanaka 2008 Efficient management of rheumatoid arthritis significantly reduces long-term functional disability Ann Rheum Dis 67 8 1153 1158 10.1136/ard.2007.072751 1:STN:280:DC%2BD1cvksVWmtA%3D%3D 17971459
16. N Iikuni E Inoue E Tanaka M Hara T Tomatsu N Kamatani H Yamanaka 2008 Low disease activity state with corticosteroid may not represent 'true' low disease activity state in patients with rheumatoid arthritis Rheumatology (Oxford) 47 4 519 521 10.1093/rheumatology/ken047 1:STN:280:DC%2BD1c7pslGhtg%3D%3D
17. DM van der Heijde MA van't Hof PL van Riel LA Theunisse EW Lubberts MA van Leeuwen MH van Rijswijk LB van de Putte 1990 Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score Ann Rheum Dis 49 11 916 920 10.1136/ard.49.11.916 2256738
18. ML Prevoo MA van't Hof HH Kuper MA van Leeuwen LB van de Putte PL van Riel 1995 Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 1 44 48 10.1002/art.1780380107 1:STN:280:DyaK2M7hvVeqtA%3D%3D 7818570
19. N Sekiguchi H Kameda K Amano T Takeuchi 2006 Efficacy and safety of bucillamine, a D-penicillamine analogue, in patients with active rheumatoid arthritis Mod Rheumatol 16 2 85 91 10.1007/s10165-005-0466-y 1:CAS:528:DC%2BD28XjslKit70%3D 16633927
20. H Nakamura Y Ueki S Sakito K Matsumoto M Yano S Miyake Y Tominaga K Eguchi 2000 Clinical effects of actarit in rheumatoid arthritis: improvement of early disease activity mediated by reduction of serum concentrations of nitric oxide Clin Exp Rheumatol 18 4 445 450 1:STN:280:DC%2BD3M%2FkvVGlsg%3D%3D 10949718
21. DP Lubeck 2001 A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings Pharmacoeconomics 19 8 811 818 10.2165/00019053-200119080-00003 1:STN:280:DC%2BD3MrkvFyrtw%3D%3D 11596833
22. SF Lanes LL Lanza PW Radensky RA Yood RF Meenan AM Walker NA Dreyer 1997 Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs Arthritis Rheum 40 8 1475 1481 10.1002/art.1780400816 1:STN:280: DyaK2svgt1eltg%3D%3D 9259428 (Pubitemid 27430959)
23. Mithal A, Yamanaka H, Tanaka E, Nakajima A, Kamatani N. Medical costs for care of rheumatoid arthritis in Japan. In: ISPOR first Asia-Pacific conference; 2003 September 1-3; Kobe, Japan.
24. Yamanaka H, Mithal A, Tanaka E, Nakajima A, Kamatani N. Medical costs are significantly associated with disability levels in rheumatoid arthritis in Japan. In: ISPOR first Asia-Pacific conference; 2003 September 1-3; Kobe, Japan.
25. G Kobelt K Eberhardt L Jönsson B Jönsson 1999 Economic consequences of the progression of rheumatoid arthritis in Sweden Arthritis Rheum 42 2 347 356 10.1002/1529-0131(199902)42:2<347::AID-ANR18>3.0.CO;2-P 1:STN:280:DyaK1M7kvVOqtQ%3D%3D 10025930 (Pubitemid 29072853)
26. E Yelin LA Wanke 1999 An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline Arthritis Rheum 42 6 1209 1218 10.1002/1529-0131(199906)42:6<1209:: AID-ANR18>3.0.CO;2-M 1:STN:280:DyaK1M3pt1agtA%3D%3D 10366114 (Pubitemid 29268958)
27. JF Fries 1999 Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis Ann Rheum Dis 58 Suppl 1 I86 I89 10.1136/ard.58.2008.i86 1:CAS:528:DC%2BD3cXivFGktQ%3D%3D 10577980
28. C Lajas L Abasolo B Bellajdel C Hernández-García L Carmona E Vargas P Lázaro JA Jover 2003 Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study Arthritis Rheum 49 1 64 70 10.1002/art.10905 12579595
29. K Michaud J Messer HK Choi F Wolfe 2003 Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients Arthritis Rheum 48 10 2750 2762 10.1002/art.11439 14558079 (Pubitemid 37280602)